ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2019

Type / Class
Debt / NOTE 2.750%10/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2019 Q3 $0 $0 -$15,000 0
2019 Q2 $4,000 $15,000 375.0% 1
2019 Q1 $4,000 $20,000 500.0% 1
2018 Q4 $4,000 $13,000 325.0% 1
2018 Q3 $4,000 $12,000 300.0% 1
2018 Q2 $4,000 $10,000 -$2,500 250.0% 1
2018 Q1 $5,000 $13,000 260.0% 1
2017 Q4 $5,000 $15,000 300.0% 1
2017 Q3 $5,000 $15,000 300.0% 1
2017 Q2 $5,000 $15,000 300.0% 1
2017 Q1 $5,000 $12,000 240.0% 1
2016 Q4 $5,000 $14,000 -$136,524,000 280.0% 1
2016 Q3 $61,104,000 $136,535,000 +$2,221,204 223.09% 6
2016 Q2 $60,104,000 $90,734,000 -$10,928,606 151.24% 6
2016 Q1 $56,104,000 $139,212,000 -$1,892,954 248.42% 6
2015 Q4 $55,605,000 $207,636,000 +$6,109,614 373.67% 7
2015 Q3 $52,320,000 $128,264,000 -$15,911,752 244.75% 7
2015 Q2 $52,326,000 $181,360,000 -$40,201,392 347.32% 9
2015 Q1 $57,328,000 $220,424,000 -$48,493,857 384.13% 11
2014 Q4 $57,517,000 $213,929,000 -$364,558,019 371.58% 11
2014 Q3 $193,798,000 $469,382,000 -$20,684,906 242.25% 19
2014 Q2 $202,102,000 $445,749,000 +$4,537,234 220.13% 18
2014 Q1 $193,850,000 $520,965,000 -$11,670,285 268.32% 19